Insider Transactions in Q3 2024 at Ultragenyx Pharmaceutical Inc. (RARE)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 16
2024
|
Theodore Alan Huizenga SVP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
700
+1.63%
|
-
|
|
Sep 03
2024
|
Theodore Alan Huizenga SVP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
91
-0.22%
|
$5,096
$56.19 P/Share
|
|
Sep 03
2024
|
Emil D Kakkis President & CEO |
SELL
Open market or private sale
|
Indirect |
20,000
-0.89%
|
$1,100,000
$55.85 P/Share
|
|
Aug 06
2024
|
Emil D Kakkis President & CEO |
SELL
Open market or private sale
|
Indirect |
20,000
-0.88%
|
$1,000,000
$50.17 P/Share
|
|
Jul 02
2024
|
Corazon (Corsee) D. Sanders |
SELL
Open market or private sale
|
Direct |
584
-4.64%
|
$23,360
$40.98 P/Share
|